F. Petersen

J. Dipersio, R. Soiffer, R. Negrin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

D. Denning, T. Walsh, M. Boogaerts, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

transplantation for breast cancer marrow ablative chemotherapy and allogeneic bone marrow Evidence for a graft-versus-tumor effect in a patient treated with

D. Nachbaur, H. Schwaighofer, A. Gächter, 2011 .

Long-term survival from respiratory failure after marrow transplantation for malignancy.

S. Crawford, F. Petersen, 1992, The American review of respiratory disease.

Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML

M. Pulsipher, F. Petersen, J. Asch, 2004, Bone Marrow Transplantation.

Pulmonary venoocclusive disease following bone marrow transplantation.

D. Madtes, J. Clark, R. Hackman, 1989, Transplantation.

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.

R. Chopra, A. Goldstone, T. Philip, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

THE USE OF RANITIDINE IN BONE MARROW TRANSPLANTATION: A Review Of 223 Cases

A. Shields, E. Thomas, F. Petersen, 1988, Transplantation.

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms

R. Storb, F. Baron, B. Sandmaier, 2019, Haematologica.

Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.

F. Petersen, D. Hoda, B. Webb, 2016, American journal of infection control.

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

M. Maris, R. Storb, B. Sandmaier, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning with HLA-Matched Related (MRD), Unrelated (URD), and Related Haploidentical (Haplo) Donors for Relapsed or Refractory Hodgkin Lymphoma (HL).

M. Maris, R. Storb, B. Sandmaier, 2007 .

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.

S. Crawford, F. Appelbaum, G. Schoch, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.

M. Maris, R. Storb, B. Sandmaier, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.

F. Appelbaum, J. Bianco, J. Singer, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

M. Maris, R. Storb, B. Sandmaier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.

R. Storb, F. Appelbaum, T. Gooley, 1994, Bone marrow transplantation.

Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia

F. Petersen, C. Ford, 2009, Current opinion in oncology.

Good and poor mobilizing patients differ in mobilized CD34+ cell adhesion molecule profiles

Jeffrey L. Anderson, D. Handrahan, F. Petersen, 2004, Transfusion.

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.

H. Deeg, B. Sandmaier, F. Appelbaum, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

K. Sullivan, F. Appelbaum, A. Back, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term effects and quality of life in children and adults after marrow transplantation.

P. Beatty, C. Anasetti, R. Witherspoon, 1989, Bone marrow transplantation.

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.

F. Appelbaum, W. Dalton, J. Bianco, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CR with lenalidomide in del(5)(q13q33) AML relapsing after allogeneic hematopoietic SCT

F. Petersen, J. Asch, C. Ford, 2010, Bone Marrow Transplantation.

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

P. Richardson, F. Baron, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis.

R. Storb, J. Sanders, F. Petersen, 1991, Blood.

CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte–colony‐stimulating factor alone and chemotherapy followed by granulocyte–colony‐stimulating factor

Jeffrey L. Anderson, F. Petersen, J. Greenwood, 2006, Transfusion.

Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience *

K. Sullivan, R. Storb, F. Appelbaum, 1989, European journal of haematology. Supplementum.

Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome.

D. Schwartz, S. Crawford, J. Clark, 1988, The American review of respiratory disease.

Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.

F. Appelbaum, J. Denney, L. Fisher, 1990, Bone marrow transplantation.

Marrow transplantation in patients with acute myeloid leukemia.

F. Appelbaum, J. Bianco, F. Petersen, 1992, Leukemia.

Marrow harvesting for autologous marrow transplantation.

F. Appelbaum, J. Sanders, W. Bensinger, 1985, Experimental hematology.

Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine

R. Storb, C. Anasetti, F. Petersen, 1990, Blut.

A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation.

G. McDonald, S. Slichter, H. Shulman, 1990, Bone marrow transplantation.

Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors

K. Sullivan, R. Storb, F. Appelbaum, 1988 .

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

J. Radich, G. Schoch, J. Hansen, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Supportive care of the marrow transplant recipient: the Seattle Experience.

K. Sullivan, F. Appelbaum, J. Meyers, 1990, Haematology and blood transfusion.

Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia

J. Singer, K. Sullivan, R. Storb, 1990 .

Allogeneic and autologous bone marrow transplantation for acute leukemia and malignant lymphoma: Current status

F. Petersen, C. Buckner, 1987, Hematological oncology.

Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia.

J. Thompson, M. Benyunes, F. Petersen, 1993, Bone marrow transplantation.

Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.

R. Storb, F. Appelbaum, J. Hansen, 1991, Bone marrow transplantation.

Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.

R. Storb, F. Appelbaum, P. Martin, 1993, Bone marrow transplantation.

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

P. Hari, M. Maris, R. Storb, 2014, Haematologica.

Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.

K. Sullivan, R. Storb, F. Appelbaum, 1989, Bone marrow transplantation.

Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.

R. Storb, F. Appelbaum, J. Sanders, 1995, Bone marrow transplantation.

Effect of prior chemotherapy on hematopoietic stem cell mobilization

F. Petersen, W. Green, C. Ford, 2004, Bone Marrow Transplantation.

Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.

R. Storb, F. Appelbaum, J. Hansen, 1995, Bone marrow transplantation.

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

M. Abecassis, P. Richardson, F. Baron, 2016, Bone Marrow Transplantation.

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

P. Hari, R. Storb, B. Sandmaier, 2013, Biology of Blood and Marrow Transplantation.

Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.

H. Deeg, F. Appelbaum, R. Storb, 1995, International journal of radiation oncology, biology, physics.

Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.

H. Deeg, K. Sullivan, R. Storb, 1992, International journal of radiation oncology, biology, physics.

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

E. Anaissie, J. Perfect, J. Wingard, 2002, The New England journal of medicine.

The prophylactic use of low-dose amphotericin B in bone marrow transplant patients.

P. Beatty, T. Evans, A. Pavia, 1994, The American journal of medicine.

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

R. Vij, G. Papanicolaou, M. Boeckh, 2008, Blood.

The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.

K. Sullivan, M. Thornquist, J. Meyers, 1987, Bone marrow transplantation.

Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin

R. Storb, B. Sandmaier, P. Mcsweeney, 2013, Bone Marrow Transplantation.

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.

F. Appelbaum, P. Beatty, C. Anasetti, 1990, Blood.

Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.

F. Appelbaum, P. Beatty, C. Anasetti, 1994, Bone marrow transplantation.

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.

K. Sullivan, R. Storb, F. Appelbaum, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mixed Hematologic Chimerism After Allogeneic Marrow Transplantation for Severe Aplastic Anemia Is Associated With a Higher Risk of Graft Rejection and a Lessened Incidence of Acute Graft-Versus-Host Disease

R. Storb, F. Petersen, K. Doney, 1986 .

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.

D. Snydman, M. Territo, P. Chandrasekar, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Conditioning regimens in bone marrow transplantation

I. Bernstein, R. Storb, B. Sandmaier, 1991 .

Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.

F. Appelbaum, P. Beatty, E. Bryant, 1991, Blood.

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.

M. Maris, R. Storb, B. Sandmaier, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Design and Use of Double Lumen Right Atrial Catheters in Bone Marrow Transplant Recipients

J. Meyers, J. Sanders, F. Petersen, 1985, Acta anaesthesiologica Scandinavica. Supplementum.

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

M. Abecassis, P. Richardson, F. Baron, 2015, Bone Marrow Transplantation.

Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis.

R. Storb, H. Greinix, J. Sanders, 1992, Bone marrow transplantation.

Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.

F. Appelbaum, M. Benyunes, P. Martin, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia

K. Sullivan, R. Storb, F. Appelbaum, 2003 .

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

A. Nademanee, J. Fay, R. Storb, 1998, Blood.

Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.

R. Storb, F. Appelbaum, E. Thomas, 1986, Blood.

Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.

P. Martin, W. Bensinger, F. Petersen, 1987, Experimental hematology.

Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.

R. Storb, S. Slichter, E. Thomas, 1989, Bone marrow transplantation.

Collection and transportation of human bone marrow cells from unrelated donors.

J. Hansen, E. Thomas, F. Petersen, 1991, Transfusion science.

Successful second transplant from an HLA-identical unrelated donor after graft rejection in a patient with chronic myelogenous leukemia.

F. Fend, D. Niederwieser, D. Nachbaur, 1994, Transplantation.

Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.

R. Storb, F. Appelbaum, J. Sanders, 1996, Bone marrow transplantation.

Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.

H. Deeg, K. Sullivan, R. Storb, 1992, Bone marrow transplantation.

Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

M. Maris, R. Storb, B. Sandmaier, 2006 .

Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.

F. Appelbaum, N. Flournoy, E. Thomas, 1988, Bone marrow transplantation.

Amlodipine and Calcineurin Inhibitor Induced Nephrotoxicity Following Allogeneic Hematopoietic Stem Cell Transplant

F. Petersen, D. Hoda, C. Ford, 2018 .

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

J. Panse, M. Maris, R. Storb, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bacterial, Fungal, and Protozoan Infection After Marrow Transplantation

K. Sullivan, E. Reed, S. Skerrett, 1988 .

An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors

F. Petersen, C. Ford, W. Reilly, 2003, Transfusion.

Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients

F. Petersen, D. Hoda, B. Webb, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

P. Hari, M. Sorror, M. Maris, 2011, JAMA.

High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.

K. Sullivan, R. Storb, F. Appelbaum, 1989, Bone marrow transplantation.

Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation

F. Petersen, B. Webb, B. Lopansri, 2017, Infection Control & Hospital Epidemiology.

The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study

M. Thornquist, J. Meyers, E. Thomas, 1988, Infection.

Fate of right atrial catheters inserted prior to arrival at a transplant center.

J. Meyers, J. Sanders, F. Petersen, 1987, JPEN. Journal of parenteral and enteral nutrition.

Phase III Study Comparing Methotrexate and Tacrolimus ( Prograf , FK 506 ) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

A. Nademanee, J. Fay, R. Storb, 1998 .

High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.

C. Anasetti, P. Martin, J. Sanders, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hickman catheter complications in marrow transplant recipients.

J. Meyers, J. Sanders, F. Petersen, 1986, JPEN. Journal of parenteral and enteral nutrition.

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

R. Vij, G. Papanicolaou, M. Boeckh, 2006 .

Effects of treatment regimens on post marrow transplant relapse.

K. Sullivan, R. Storb, F. Appelbaum, 1991, Seminars in hematology.

A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients.

M. Grimm, F. Petersen, C. Bennett, 1990, JPEN - Journal of Parenteral and Enteral Nutrition.

Midostaurin and cyclosporine drug interaction: A case report

R. Mancini, F. Petersen, William H Kreisle, 2019, Journal of clinical pharmacy and therapeutics.

A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A M

M. Maris, R. Storb, B. Sandmaier, 2009 .

Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.

K. Sullivan, R. Storb, F. Appelbaum, 1991, Bone marrow transplantation.

Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.

R. Storb, F. Appelbaum, H. Shulman, 1987, Cancer treatment reports.

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

M. Sorror, M. Maris, R. Storb, 2008 .

Controlled rate freezing of human marrow in a constant temperature cooling gradient in air.

F. Petersen, Á. Figuera, C. Buckner, 1986, Cryobiology.

Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan--report of a case.

R. Storb, J. Sanders, W. Bensinger, 1988, Transplantation.

Autologous bone marrow transplantation in primary breast cancer : the American experience

J. Fay, L. Akard, C. Cirrincione, 1995 .

Autologous bone marrow transplantation for acute lymphoblastic leukemia.

H. Deeg, F. Appelbaum, C. Anasetti, 1993, Bone marrow transplantation.

Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation

F. Petersen, D. Hoda, B. Webb, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.

F. Petersen, D. Hoda, B. Webb, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The clinical impact of vancomycin‐resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation

F. Petersen, B. Lopansri, M. Gazdik, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphoma.

F. Appelbaum, F. Petersen, C. Buckner, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.

J. Armitage, J. Vose, M. Horowitz, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

M. Pepe, K. Sullivan, R. Storb, 1991, Transplantation.

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

J. Fay, R. Storb, S. Davies, 2000, Blood.

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia

M. Maris, R. Storb, B. Sandmaier, 2008 .

Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience.

F. Appelbaum, J. Sanders, F. Petersen, 1992, Leukemia.

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

K. Sullivan, K. Kopecky, J. Meyers, 1990, The New England journal of medicine.

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

P. Hari, R. Storb, B. Sandmaier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Panse, M. Maris, R. Storb, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.